^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Colon Cancer |
| Drug: | 5-fluorouracil (Thymidylate synthase inhibitor) + irinotecan (Topoisomerase I inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
01/30/2020
Excerpt:
CAMPTOSAR is a topoisomerase inhibitor indicated for...First-line therapy in combination with 5-fluorouracil and leucovorin for patients with metastatic carcinoma of the colon or rectum.
Secondary therapy:
leucovorin calcium
